CHRONIC HEPATITIS D INFECTION

Clinical trials for CHRONIC HEPATITIS D INFECTION explained in plain language.

Never miss a new study

Get alerted when new CHRONIC HEPATITIS D INFECTION trials appear

Sign up with your email to follow new studies for CHRONIC HEPATITIS D INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

New hope for rare liver disease: libevitug enters final trial phase

Disease control Not yet recruiting

This study tests a new drug called libevitug for people with chronic hepatitis D, a serious liver infection. About 160 adults will receive either a low or high dose of the drug every two weeks for 96 weeks, or be placed in a control group that starts treatment later. The goal is …

Matched conditions: CHRONIC HEPATITIS D INFECTION

Phase: PHASE3 • Sponsor: Huahui Health • Aim: Disease control

Last updated May 13, 2026 16:00 UTC

CHRONIC HEPATITIS D INFECTION

Get alerted when new CHRONIC HEPATITIS D INFECTION trials appear

New hope for rare liver disease: libevitug enters final trial phase